None listed
Conditions
Interventions
Valdecoxib 40 mg will be administered twice a day on the first day and 40 mg once a day until the seventh day.
Group name:Diclofenac 75 mg Type of group
Diclofenac 75 mg will be administered twice daily for seven days.
Sponsors
PHARMACIA & UPJOHN INTERAMERICAN CORPORATION,
Eligibility
Inclusion criteria
Inclusion criteria: Men or women> 18 years old with the legal age required to grant their consent. Women who are postmenopausal or surgically sterilized, or who have had a urine pregnancy test with a negative result before randomization.Men or women> 18 years old with the legal age required to grant their consent. Women who are postmenopausal or surgically sterilized, or who have had a urine pregnancy test with a negative result before randomization.
Exclusion criteria
Exclusion criteria: Clinical evidence of complete rupture of the ligaments of the ankle (sprain of third degree). Requires bed rest, hospitalization, surgical intervention to ankle injury or complete non-removable cast of any kind. presence of bilateral ankle injury or ipsilateral ankle injury and knee. A similar injury to the same joint suffered in the last six months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Outcome name:Visual Analogue Scale Measure:Evaluation of the Ankle Pain made by the Patient using a Visual Analogue Scale, measured on a scale of 0-100 mm. Timepoints:4 day | — |
Secondary
| Measure | Time frame |
|---|---|
| Outcome name:Visual Analogue Scale Measure:The Ankle Pain Assessment performed by the Patient using a Visual Analogue Scale supporting the weight on Day 7 Timepoints:day 7 | — |
Countries
Argentina, Chile, Colombia, Mexico, Peru
Outcome results
None listed